Physician-Reviewed Protocol

Sermorelin · 5ML

Sermorelin is a GHRH analogue studied for stimulating endogenous growth hormone secretion with a favorable safety profile. Physician-reviewed. Prescription required.

Longevity GH Secretagogue Prescription Required
What It Is
Sermorelin 5ML

Mechanism of Action

Sermorelin is a synthetic analog of GHRH that acts primarily on the pituitary gland to stimulate endogenous growth hormone secretion. Its mechanism is receptor-mediated, working through the natural GH axis.

Unlike exogenous GH, sermorelin works through the body's natural feedback mechanisms, which may offer a more favorable safety profile. It has been studied for GH restoration and sleep quality. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

Mechanism Biological Effect
GHRH receptor agonism Stimulates endogenous GH secretion
cAMP/PKA signaling Promotes GH release from somatotrophs
Pulsatile GH amplification Physiologic GH elevation
Secondary IGF-1 production Anabolic effects
Reduced side effect profile Safer than exogenous GH therapy
Candidate Profile

Who It's Designed For

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with Sermorelin protocol candidates in clinical practice:

GH Decline

Individuals with age-related GH decline seeking physician-supervised secretagogue therapy.

Body Composition

Individuals seeking physician-supervised GH secretagogue therapy for metabolic evaluation.

Sleep Quality

Individuals with sleep disruption where GH-mediated sleep architecture support may be clinically relevant.

Physician Evaluation

Individuals seeking physician-supervised GH axis evaluation and protocol consideration.

Determine your candidacy

A physician will review your intake and make eligibility determination within 24–48 hours.

Outcomes & Timeline

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Weeks 1–4
Early-stage signaling activity may be observed. Individual outcomes may differ. Physician monitoring recommended.
Weeks 4–8
In clinical and preclinical settings, progressive signaling activity has been associated with continued administration in clinical settings. Individual outcomes vary significantly. Physician monitoring recommended throughout.
Weeks 8–12
Sustained physician-supervised administration may support continued outcomes. Your physician will evaluate protocol continuation.
Dosing Overview

Protocol Structure

Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.

Typical Range

200–500 mcg/day

Administration

Subcutaneous injection

Duration

12–24 weeks (physician-determined)

Frequency

Once daily at bedtime (physician-determined)

These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.

What's Included

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Contraindications & Safety Notes

Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.

Active malignancy: GH-stimulating peptides are reviewed carefully in cancer history contexts.
Pregnancy or lactation: Not indicated. Contraindicated in pregnant or nursing individuals.
Hypothyroidism: Untreated hypothyroidism may reduce sermorelin efficacy. Thyroid status reviewed at intake.
Current medications: Disclose all medications and supplements during intake.
FAQ

Common Questions

This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness. Do not combine protocols without explicit physician guidance.
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized. Reorder notification is sent 10 days before your protocol completes.
Sermorelin
VERUM HEALTH
From $200
Prescription required